(2R,3R,4S,6S)-6-(((2R,3S,4S,6S)-6-(((2R,3S,4S,6R)-6-(((3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2,5-dihydrofuran-3-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-4-hydroxy-2-methyltetrahydro-2H-pyran-3-yl)oxy)-4-hydroxy-2-methyltetrahydro-2H-pyran-3-yl)oxy)-3-hydroxy-2-methyltetrahydro-2H-pyran-4-yl acetate;(3?,5?,12?)-3-[(O-3-O-Acetyl-2,6-dideoxy-?-D-ribo-hexopyranosyl-(14)-O-2,6-dideoxy-?-D-ribo-hexopyranosyl-(14)-2,6-dideoxy-?-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide; 3'''-Acetyldigoxin; Desglucolanatoside C; Lanatilin;?-Acetyl Digoxin
Digoxin Impurity I is a fully characterized chemical compound used as a reference standard of API Digoxin. The standard offered is compliant with regulatory guidelines. Digoxin Impurity I is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 5511-98-8
